Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford progeria syndrome is a research paper published in eLife (2023). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart Lung & Blood Institute
Grant: R01 HL105297
National Institute on Aging
Grant: R21 AG067347
National Institutes of Health
Grant: 5R01HL105297-02
Mechanisms Underlying the Progression of Arterial Stiffness in Hypertension
National Institutes of Health
Grant: 5R21AG067347-02
NON-NUCLEASE BASED GENE EDITING FOR HUTCHINSON-GILFORD PROGERIA
Inozyme Pharma
FWCI
1.68
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals